Just Published: How fast-growing algae could enhance growth of crops
May 19, 2022

A study by Martin Jonikas and Ned Wingreen provides a framework to boost crop growth by incorporating a strategy adopted from a fast-growing species of green algae. 

Princeton to unveil a portrait of Elaine Fuchs *77
May 4, 2022

As part of the University’s ongoing initiative to expand the narrative of Princeton’s history and foster an inclusive sense of place on campus, the University is unveiling a portrait of Elaine Fuchs *77.

Tethers bring distant genes together to coordinate embryo development
May 4, 2022

Michael Levine and Thomas Gregor publish studies that shed light on the coordination of genes during embryonic development in Nature.

Princeton's Year of the Tiger series features Yibin Kang
April 29, 2022

The Year of the Tiger that launched with this Lunar New Year is a moment of pride and reflection for Princeton’s vibrant Asian and Asian American community. This month, the University continues the series with Yibin Kang.

Adamson, Posfai, and Jonikas Awarded Schmidt Technology Grants
April 28, 2022

New research endeavors with potential benefits for health, the environment, and molecular imaging have been awarded support from the Eric and Wendy Schmidt Transformative Technology Fund.

Molecular Biology concentrator Natalia Orlovsky Named Valedictorian
April 26, 2022

Natalia Orlovsky, a molecular biology concentrator from Chadds Ford, Pennsylvania, has been selected as valedictorian of Princeton’s Class of 2022. Frances Mangina, a philosophy concentrator from Toronto, was named salutatorian. 

Josh Babu ’22 profiled for research on transgender youth’s long-term health care
April 20, 2022

For Josh Babu ’22, a pre-med concentrator in the Department of Molecular Biology and Rhodes Scholar, a certificate in Gender and Sexuality Studies (GSS) might not seem like the most obvious choice. Far from it, his studies in the GSS department actually led him to the topic of his senior thesis.

Yibin Kang Awarded IP Accelerator Funding
April 15, 2022

Projects are selected following a competitive application process that includes evaluation based on scientific and technical merit, innovation and novelty, the ability of the technology to meet a market or societal need, and the potential for public benefit.

Celia Smits Awarded Procter Fellowship
April 14, 2022

Smits is a 5th year graduate student in the Shvartsman lab. The Procter Fellowship is awarded annually “to students displaying the highest scholarly excellence in graduate work.”

MOL Graduate Students Chloe Cavanaugh, Will Hofstadter and Collin McManus win 2022 Teaching Awards
April 12, 2022

Three MOL graduate students have been awarded 2022 Teaching Awards by the Dean of the Graduate School. Teaching Awards honor those graduate students who have made a significant and exceptional contribution to undergraduate teaching. 

Alice Zhang '10 co-founder of Verge Genomics talks to PAW
April 6, 2022

MOL BIO major Alice Zhang '10 is featured on the cover of this week's PAW and interviewed about the company she co-founded, Verge Genomics

New study reveals insights into how early immune response defines severity of COVID-19
April 6, 2022

Researchers at Princeton University and Boston University have uncovered new insights into the role played by the earliest stages of the immune response to SARS-CoV-2 in determining whether patients develop mild or severe forms of COVID-19.

Lewis Thomas Laboratory Hosts CDC Director Walensky
March 25, 2022

Dr. Rochelle Walensky, director of the CDC, visited Princeton March 24 to tour the University’s COVID-19 testing laboratory and speak about her public health career during a lecture organized by members of the Class of 2022.

KayoThera, Inc. Raises $8 Million to Develop Novel Cancer Immunotherapeutics
March 16, 2022

KayoThera’s science is based on research conducted by Mark Esposito and Yibin Kang, who co-founded KayoThera in 2019 to pursue the development of therapies based on their research.

Spinout from Gitai lab announces seed funding and hiring of CEO
March 6, 2022

ArrePath, a drug discovery spinout founded by Zemer Gitai, has announced a seed round of $20 million to advance its proprietary, machine learning-based platform for discovering new classes of anti-infectives.